Polypid ltd.PYPD.US Overview

US StockHealthcare

(No presentation for PYPD)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

PYPD Overall Performance

PYPD AI Analysis & Strategy

PYPD Recent Performance

-1.95%

Polypid ltd.

0.81%

Avg of Sector

-1.14%

S&P500

PYPD PowerScanner

PYPD Key Information

PYPD Valuation Metrics

PYPD Earnings Table

PYPD Profile

PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.